2014
DOI: 10.1264/jsme2.me13178
|View full text |Cite
|
Sign up to set email alerts
|

Antimicrobial Activity of Pantothenol against Staphylococci Possessing a Prokaryotic Type II Pantothenate Kinase

Abstract: Pantothenol is a provitamin of pantothenic acid (vitamin B5) that is widely used in healthcare and cosmetic products. This analog of pantothenate has been shown to markedly inhibit the phosphorylation activity of the prokaryotic type II pantothenate kinase of Staphylococcus aureus, which catalyzes the first step of the coenzyme A biosynthetic pathway. Since type II enzymes are found exclusively in staphylococci, pantothenol suppresses the growth of S. aureus, S. epidermidis, and S. saprophyticus, which inhabit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 21 publications
0
4
0
1
Order By: Relevance
“…Dexpanthenol has other properties making it ideal for use in the application being discussed here, specifically improvement during wound healing [45‐47]. It is also linked with reduction of oxidative stress [36], reduces Keratin Growth Factor (KGF) expression (important in growth and differentiation of the SC and barrier development) [48], has anti‐irritation properties [49] and antimicrobial activity against a range of skin bacteria including Staphylococcus aureus [50].…”
Section: Resultsmentioning
confidence: 99%
“…Dexpanthenol has other properties making it ideal for use in the application being discussed here, specifically improvement during wound healing [45‐47]. It is also linked with reduction of oxidative stress [36], reduces Keratin Growth Factor (KGF) expression (important in growth and differentiation of the SC and barrier development) [48], has anti‐irritation properties [49] and antimicrobial activity against a range of skin bacteria including Staphylococcus aureus [50].…”
Section: Resultsmentioning
confidence: 99%
“…Pantothenate is involved in the Coenzyme A (CoA) synthesis, which functions as an acyl carrier and is a required cofactor for all living cells. Pantothenate analogs also have been shown to markedly suppress the growth of some opportunistic pathogens by inhibiting phosphorylation activity, which catalyzes the first step of the CoA biosynthetic pathway in specific bacteria, such as Staphylococcus species that inhabit human skin including Staphylococcus epidermidis, Staphylococcus saprophyticus, and Staphylococcus aureus ( 115 , 116 ), the most common microorganism identified in mastitis among lactating mothers ( 117 , 118 ), suggesting pantothenate to be effective in preventing infections by opportunistic pathogens. In our study, Staphylococcus aureus was not identified as DA by infant growth and was not correlated with maternal intake of vitamin B5, possibly due to our exclusion criteria of mastitis and sub-clinical mastitis which might have yielded low abundance of Staphylococcus aureus in our study population.…”
Section: Discussionmentioning
confidence: 99%
“…Both β-alanine and pantothenate promoted CAP resistance, verifying that the pantothenate pathway played an important role in CAP resistance. On the one hand, Pantothenol (pB5) is a provitamin of pantothenate, an inhibitor of the phosphorylation activity of the prokaryotic pantothenate kinase, which catalyzes the first step of the coenzyme A biosynthetic pathway ( Chohnan et al, 2014 ). Pantothenol decreased the percent survival rate, which showed that sensitivity to CAP increased when the pantothenate pathway was blocked.…”
Section: Discussionmentioning
confidence: 99%